Woodline Partners LP Silverback Therapeutics, Inc. Transaction History

Woodline Partners LP

  • $10.5 Billion
  • Q1 2024

A detailed history of Woodline Partners LP transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 401,788 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
401,788
Previous 661,414 39.25%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
N/A
-259,626 Reduced 39.25%
401,788 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-185,640 Reduced 21.92%
661,414 $0
Q3 2023

Nov 14, 2023
BUY
N/A
176,967 Added 26.41%
847,054 $0
Q2 2023

Aug 14, 2023
BUY
N/A
70,087 Added 11.68%
670,087 $0
Q1 2023

May 15, 2023
SELL
N/A
-661,307 Reduced 52.43%
600,000 $0
Q4 2022

Feb 14, 2023
BUY
$0.0 - $6.07 $0 - $2.72 Million
448,408 Added 55.16%
1,261,307 $0
Q3 2022

Nov 14, 2022
BUY
$3.91 - $5.52 $3.18 Million - $4.49 Million
812,899 New
812,899 $4.29 Million
Q2 2022

Aug 15, 2022
SELL
$2.9 - $4.44 $242,355 - $371,055
-83,571 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.51 - $6.74 $1.44 Million - $2.77 Million
-410,324 Reduced 83.08%
83,571 $293,000
Q4 2021

Feb 14, 2022
BUY
$6.03 - $11.67 $413,863 - $800,958
68,634 Added 16.14%
493,895 $3.29 Million
Q3 2021

Nov 15, 2021
BUY
$9.98 - $35.22 $475,347 - $1.68 Million
47,630 Added 12.61%
425,261 $4.24 Million
Q2 2021

Aug 16, 2021
BUY
$24.71 - $44.28 $4.22 Million - $7.57 Million
170,948 Added 82.71%
377,631 $11.7 Million
Q1 2021

May 17, 2021
SELL
$37.62 - $60.41 $333,049 - $534,809
-8,853 Reduced 4.11%
206,683 $9.02 Million
Q4 2020

Feb 16, 2021
BUY
$25.0 - $46.34 $5.39 Million - $9.99 Million
215,536 New
215,536 $9.99 Million

Others Institutions Holding SBTX

# of Institutions
117
Shares Held
47.9M
Call Options Held
442K
Put Options Held
42K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email